Pharma Capsules - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharma Capsules
Brief pharmaceutical news items for March 2008.

Pharmaceutical Technology


Cognex Launches New Website


Cognexs new website.
Cognex's (Natick, MA) new website, http://www.cognex.com/, is designed to illustrate how manufacturers can use vision to optimize product quality and reduce manufacturing costs.

The site includes more than 80 application case studies, selectable by industry and application, that show how customers benefit from Cognex's machine vision solution. One section of the site gives visitors options for learning more about vision technology through seminars, training programs, and tradeshows.

The website is easy to navigate and provides details about Cognex's products. Information for more than 35 countries is available in nine languages.

People

Egenix Appoints Scientific Advisor

Egenix (Millbrook, NY), named Daniel Petrylak chairman of the company's scientific advisory board. Petrylak is an associate professor of medicine at Columbia University Medical Center, where he is director of genitourinary oncology.

Egenix is a privately held biotechnology company working to create effective cancer therapies. The company is working to develop small-molecule inhibitors of translation initiation, a new paradigm in target-specific, noncytotoxic anticancer therapy.


ADVERTISEMENT

RELATED CONTENT
Pharma Capsules
Pharma Capsules
Pharma Capsules
Pharma Capsules
Pharma Capsules
blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here